Related stories
Collegium Pharmaceutical Reports Third-Quarter Revenue of $216.34 Million
Collegium Pharmaceutical’s product revenues rose as higher Jornay PM sales and the addition of Azstarys more than offset declines in Nucynta, Xtampza ER, Belbuca and Symproic. Net
M impact | EQUITY | Nov 05, 2026, 12:43 PM UTC
Graham Reports Fiscal Third-Quarter Revenue of $69.76 Million, EPS of $0.39
Graham’s second-quarter fiscal 2027 net sales and earnings increased year over year, with sales growth reflecting the FlackTek acquisition and gains in Defense and Space.
M impact | EQUITY | Nov 05, 2026, 12:43 PM UTC
Tube Investments Q2 Consolidated Profit Rises 39% to ₹420 Crore
Tube Investments of India reported consolidated revenue of ₹7,330 crore for the quarter ended September 2026, versus ₹5,523 crore a year earlier. Standalone PAT was flat.
M impact | EQUITY | Nov 05, 2026, 12:43 PM UTC
Fastenal October Net Sales Rise 12.0% to $863.5 Million
Fastenal reported October net sales of $863.5 million, up 12.0% year over year from $771.0 million. Daily sales growth accelerated to 17.1%.
M impact | EQUITY | Nov 05, 2026, 12:42 PM UTC
Cabaletta Bio Extends Cash Runway Into 1Q 28
Cabaletta Bio reported a cash position of $299.4 million as of Sept. 30 and an operational runway extending into 1Q 28.
L impact | EQUITY | Nov 05, 2026, 12:42 PM UTC
Nova Ltd. Reports Q3 Revenue of $287.8M Versus FactSet Estimate of $282.2M
M impact | EQUITY | Nov 05, 2026, 12:42 PM UTC